Does Hürthle cell carcinoma of the thyroid have a poorer prognosis than ordinary follicular thyroid carcinoma?

Kiminori Sugino, Kaori Kameyama, Koichi Ito, Mitsuji Nagahama, Wataru Kitagawa, Hiroshi Shibuya, Keiko Ohkuwa, Takashi Uruno, Junko Akaishi, Akifumi Suzuki, Chie Masaki, Kunihiko Ito

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: Hürthle cell carcinoma (HCC) is a rare form of thyroid carcinoma and is considered an oxyphilic variant of follicular thyroid carcinoma. However, little is known about its biological characteristics or clinical behavior. We conducted a retrospective study to determine whether the prognosis of HCC differs from that of ordinary follicular thyroid carcinoma (OFC). Methods: The subjects were the 558 patients with follicular thyroid carcinoma who underwent initial surgery at our institution between 1989 and 2010 and consisted of 73 patients with HCC and 485 patients with OFC. There were 410 females and 148 males, and their median age was 51 years. A univariate analysis was conducted in relation to cumulative cause-specific survival (CSS) according to the Kaplan-Meier method for the following variables: age at the time of initial surgery, gender, tumor size, invasiveness, distant metastasis at presentation, and histological type (HCC vs OFC). Differences between groups were analyzed for significance by the log-rank test. Multivariate analysis was performed by using the Cox proportional hazard model. Results: A total of 4 patients (5.5 %) in the HCC group had distant metastasis compared with 106 patients (21.9 %) in the OFC group. Significant factors in relation to CSS in the univariate analyses were age, tumor size, and invasiveness, but there were no significant differences between the HCC group and the OFC group. Multivariate analysis showed that age, tumor size, and distant metastasis at presentation were significant factors. Conclusions: HCC does not have a poorer prognosis than OFC.

Original languageEnglish
Pages (from-to)2944-2950
Number of pages7
JournalAnnals of Surgical Oncology
Volume20
Issue number9
DOIs
Publication statusPublished - 2013 Sep

Fingerprint

Follicular Adenocarcinoma
Thyroid Neoplasms
Carcinoma
Neoplasm Metastasis
Multivariate Analysis
Neoplasms
Survival
Proportional Hazards Models
Retrospective Studies

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Does Hürthle cell carcinoma of the thyroid have a poorer prognosis than ordinary follicular thyroid carcinoma? / Sugino, Kiminori; Kameyama, Kaori; Ito, Koichi; Nagahama, Mitsuji; Kitagawa, Wataru; Shibuya, Hiroshi; Ohkuwa, Keiko; Uruno, Takashi; Akaishi, Junko; Suzuki, Akifumi; Masaki, Chie; Ito, Kunihiko.

In: Annals of Surgical Oncology, Vol. 20, No. 9, 09.2013, p. 2944-2950.

Research output: Contribution to journalArticle

Sugino, K, Kameyama, K, Ito, K, Nagahama, M, Kitagawa, W, Shibuya, H, Ohkuwa, K, Uruno, T, Akaishi, J, Suzuki, A, Masaki, C & Ito, K 2013, 'Does Hürthle cell carcinoma of the thyroid have a poorer prognosis than ordinary follicular thyroid carcinoma?', Annals of Surgical Oncology, vol. 20, no. 9, pp. 2944-2950. https://doi.org/10.1245/s10434-013-2965-y
Sugino, Kiminori ; Kameyama, Kaori ; Ito, Koichi ; Nagahama, Mitsuji ; Kitagawa, Wataru ; Shibuya, Hiroshi ; Ohkuwa, Keiko ; Uruno, Takashi ; Akaishi, Junko ; Suzuki, Akifumi ; Masaki, Chie ; Ito, Kunihiko. / Does Hürthle cell carcinoma of the thyroid have a poorer prognosis than ordinary follicular thyroid carcinoma?. In: Annals of Surgical Oncology. 2013 ; Vol. 20, No. 9. pp. 2944-2950.
@article{aa90054f1b6d4fe4938b14bb03eebe76,
title = "Does H{\"u}rthle cell carcinoma of the thyroid have a poorer prognosis than ordinary follicular thyroid carcinoma?",
abstract = "Background: H{\"u}rthle cell carcinoma (HCC) is a rare form of thyroid carcinoma and is considered an oxyphilic variant of follicular thyroid carcinoma. However, little is known about its biological characteristics or clinical behavior. We conducted a retrospective study to determine whether the prognosis of HCC differs from that of ordinary follicular thyroid carcinoma (OFC). Methods: The subjects were the 558 patients with follicular thyroid carcinoma who underwent initial surgery at our institution between 1989 and 2010 and consisted of 73 patients with HCC and 485 patients with OFC. There were 410 females and 148 males, and their median age was 51 years. A univariate analysis was conducted in relation to cumulative cause-specific survival (CSS) according to the Kaplan-Meier method for the following variables: age at the time of initial surgery, gender, tumor size, invasiveness, distant metastasis at presentation, and histological type (HCC vs OFC). Differences between groups were analyzed for significance by the log-rank test. Multivariate analysis was performed by using the Cox proportional hazard model. Results: A total of 4 patients (5.5 {\%}) in the HCC group had distant metastasis compared with 106 patients (21.9 {\%}) in the OFC group. Significant factors in relation to CSS in the univariate analyses were age, tumor size, and invasiveness, but there were no significant differences between the HCC group and the OFC group. Multivariate analysis showed that age, tumor size, and distant metastasis at presentation were significant factors. Conclusions: HCC does not have a poorer prognosis than OFC.",
author = "Kiminori Sugino and Kaori Kameyama and Koichi Ito and Mitsuji Nagahama and Wataru Kitagawa and Hiroshi Shibuya and Keiko Ohkuwa and Takashi Uruno and Junko Akaishi and Akifumi Suzuki and Chie Masaki and Kunihiko Ito",
year = "2013",
month = "9",
doi = "10.1245/s10434-013-2965-y",
language = "English",
volume = "20",
pages = "2944--2950",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "9",

}

TY - JOUR

T1 - Does Hürthle cell carcinoma of the thyroid have a poorer prognosis than ordinary follicular thyroid carcinoma?

AU - Sugino, Kiminori

AU - Kameyama, Kaori

AU - Ito, Koichi

AU - Nagahama, Mitsuji

AU - Kitagawa, Wataru

AU - Shibuya, Hiroshi

AU - Ohkuwa, Keiko

AU - Uruno, Takashi

AU - Akaishi, Junko

AU - Suzuki, Akifumi

AU - Masaki, Chie

AU - Ito, Kunihiko

PY - 2013/9

Y1 - 2013/9

N2 - Background: Hürthle cell carcinoma (HCC) is a rare form of thyroid carcinoma and is considered an oxyphilic variant of follicular thyroid carcinoma. However, little is known about its biological characteristics or clinical behavior. We conducted a retrospective study to determine whether the prognosis of HCC differs from that of ordinary follicular thyroid carcinoma (OFC). Methods: The subjects were the 558 patients with follicular thyroid carcinoma who underwent initial surgery at our institution between 1989 and 2010 and consisted of 73 patients with HCC and 485 patients with OFC. There were 410 females and 148 males, and their median age was 51 years. A univariate analysis was conducted in relation to cumulative cause-specific survival (CSS) according to the Kaplan-Meier method for the following variables: age at the time of initial surgery, gender, tumor size, invasiveness, distant metastasis at presentation, and histological type (HCC vs OFC). Differences between groups were analyzed for significance by the log-rank test. Multivariate analysis was performed by using the Cox proportional hazard model. Results: A total of 4 patients (5.5 %) in the HCC group had distant metastasis compared with 106 patients (21.9 %) in the OFC group. Significant factors in relation to CSS in the univariate analyses were age, tumor size, and invasiveness, but there were no significant differences between the HCC group and the OFC group. Multivariate analysis showed that age, tumor size, and distant metastasis at presentation were significant factors. Conclusions: HCC does not have a poorer prognosis than OFC.

AB - Background: Hürthle cell carcinoma (HCC) is a rare form of thyroid carcinoma and is considered an oxyphilic variant of follicular thyroid carcinoma. However, little is known about its biological characteristics or clinical behavior. We conducted a retrospective study to determine whether the prognosis of HCC differs from that of ordinary follicular thyroid carcinoma (OFC). Methods: The subjects were the 558 patients with follicular thyroid carcinoma who underwent initial surgery at our institution between 1989 and 2010 and consisted of 73 patients with HCC and 485 patients with OFC. There were 410 females and 148 males, and their median age was 51 years. A univariate analysis was conducted in relation to cumulative cause-specific survival (CSS) according to the Kaplan-Meier method for the following variables: age at the time of initial surgery, gender, tumor size, invasiveness, distant metastasis at presentation, and histological type (HCC vs OFC). Differences between groups were analyzed for significance by the log-rank test. Multivariate analysis was performed by using the Cox proportional hazard model. Results: A total of 4 patients (5.5 %) in the HCC group had distant metastasis compared with 106 patients (21.9 %) in the OFC group. Significant factors in relation to CSS in the univariate analyses were age, tumor size, and invasiveness, but there were no significant differences between the HCC group and the OFC group. Multivariate analysis showed that age, tumor size, and distant metastasis at presentation were significant factors. Conclusions: HCC does not have a poorer prognosis than OFC.

UR - http://www.scopus.com/inward/record.url?scp=84881479343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881479343&partnerID=8YFLogxK

U2 - 10.1245/s10434-013-2965-y

DO - 10.1245/s10434-013-2965-y

M3 - Article

C2 - 23616135

AN - SCOPUS:84881479343

VL - 20

SP - 2944

EP - 2950

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 9

ER -